United States · 
Who invested in Sunflower Therapeutics?
Sunflower Therapeutics's investors include National Institute of Allergy and Infectious Diseases.
United States · Funded startup
Who invested in Sunflower Therapeutics
Funding summaryUpdated 26 Oct 2026
$300Kraised across 1 round since 2025, from 1 source
- Latest round
- Grant, $300KSept 2025
- Investors
- 1
The rounds
- Sept 2025
Founders and team
From Sunflower Therapeutics's own website and the SEC filings it signed: 8 on the team.
- Jodie CrowleyChief People & Operations Officer
- Tom HeerChief Financial Officer
- Alexandra BonnymanDirector of Engineering Operations
- Dave BianchiDirector of Commercial Operations
- Devin Grace MorrisonIndustrial Design Engineer
- Martin RochefortSenior Research Associate
- Kerry R. LoveExecutive Officer, Directori
- Larry R. WeinerBoard of Directors
On the board, as filediJ. Christopher R. LoveMaik R. Jornitz
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Sunflower Therapeutics
How much has Sunflower Therapeutics raised?
Sunflower Therapeutics has raised $300K across 1 round since 2025.
When did Sunflower Therapeutics last raise?
Sunflower Therapeutics's most recent round was a Grant of $300K in Sept 2025.
What was Sunflower Therapeutics's biggest round?
Its most recent round, $300K in Sept 2025, is also its largest on record.
Who backed Sunflower Therapeutics first?
Sunflower Therapeutics's first round on record, in Sept 2025, was backed by National Institute of Allergy and Infectious Diseases.
What stage is Sunflower Therapeutics at?
Sunflower Therapeutics's latest named round is a Grant, in Sept 2025.
Where is Sunflower Therapeutics based?
Sunflower Therapeutics is based in the United States.
Companies like Sunflower Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.